Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Purpose
The purpose of this study is to measure immunity to the flu vaccine over time in patients who had COVID-19. Adults who have been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Conditions
- Corona Virus Infection
- Flu Vaccine
- Immunity
Eligibility
- Eligible Ages
- Between 18 Years and 64 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Adults enrolled in study 55689 (NCT04373148) or the general population - Adults diagnosed with severe or moderate COVID-19 at least 2 months prior enrollment - Adults without COVID-19 diagnosis for controls
Exclusion Criteria
- Received the influenza vaccine less than 4 months ago - Pregnant or lactating - Patients with special risks attendant to venipuncture - Use of immunomodulatory medications - Immunodeficiency or autoimmune disease
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Case-Control
- Time Perspective
- Prospective
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
COVID-19 participants |
|
|
Control participants |
|
Recruiting Locations
Stanford University
Palo Alto, California 94304
Palo Alto, California 94304
More Details
- NCT ID
- NCT04579588
- Status
- Recruiting
- Sponsor
- Stanford University